Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04926077 · ClinicalTrials.gov registry record · NA
DreamKit Respiratory Effort Signal Validation
A NA study, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04926077: Completed NA study, sponsored by Philips Clinical & Medical Affairs Global.
NCT04926077 is a NA study that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04926077, a NA study, has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study has been developed in order to demonstrate the validity of the DreamKit respiratory effort signal.
Primary Outcome
The primary endpoint is the intraclass correlation coefficient (ICC) of the peak-to-peak breath amplitude sequences extracted from the DreamKit and esophageal manometry respiratory effort signals during periods of occluded inspiration, end-expiratory breath holds, increased inspiratory resistance, increased expiratory resistance, and unresisted shallow breathing. The DreamKit Home Sleep Test device's effort signal is an uncalibrated signal. The amplitudes derived from the DreamKit Home Sleep Tes
Interventions
- DEVICE DreamKit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-06-22 |
| Est. Completion | 2021-10-07 |
| Phase | NA |
What the finished NCT04926077 record still lists
NCT04926077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which DreamKit is the first listed.
NCT04926077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04926077 about?
NCT04926077 is a clinical study titled "DreamKit Respiratory Effort Signal Validation". This study has been developed in order to demonstrate the validity of the DreamKit respiratory effort signal.
What is the current status of trial NCT04926077?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-06-22. Estimated completion is 2021-10-07.
What interventions are being tested in trial NCT04926077?
The interventions under investigation include: DreamKit (DEVICE).
Who is sponsoring clinical trial NCT04926077?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04926077's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI